Cargando…

Impact of Glycemic Control Strategies on the Progression of Diabetic Peripheral Neuropathy in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) Cohort

OBJECTIVE: The Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) trial demonstrated similar long-term clinical effectiveness of insulin-sensitizing (IS) versus insulin-providing (IP) treatments for type 2 diabetes on cardiovascular outcomes in a cohort with documented coronary...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pop-Busui, Rodica, Lu, Jiang, Brooks, Maria Mori, Albert, Stewart, Althouse, Andrew D., Escobedo, Jorge, Green, Jenifer, Palumbo, Pasquale, Perkins, Bruce A., Whitehouse, Fred, Jones, Teresa L.Z.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Diabetes Association 2013
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3781573/ https://www.ncbi.nlm.nih.gov/pubmed/23757426 http://dx.doi.org/10.2337/dc13-0012

Ejemplares similares

Risk Factors for Incident Peripheral Arterial Disease in Type 2 Diabetes: Results From the Bypass Angioplasty Revascularization Investigation in Type 2 Diabetes (BARI 2D) Trial
por: Althouse, Andrew D., et al.
Publicado: (2014)

Favorable Effects of Insulin Sensitizers Pertinent to Peripheral Arterial Disease in Type 2 Diabetes: Results from the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) trial
por: Althouse, Andrew D., et al.
Publicado: (2013)

The Prevalence and Predictors of an Abnormal Ankle-Brachial Index in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) Trial
por: Singh, Premranjan P., et al.
Publicado: (2011)

Association Between Increased Platelet P-Selectin Expression and Obesity in Patients With Type 2 Diabetes: A BARI 2D (Bypass Angioplasty Revascularization Investigation 2 Diabetes) substudy
por: Schneider, David J., et al.
Publicado: (2009)

Cardiac Autonomic Neuropathy in Diabetes: A clinical perspective
por: Pop-Busui, Rodica
Publicado: (2010)

An Aggregate Biomarker Risk Score Predicts High Risk of Near‐Term Myocardial Infarction and Death: Findings From BARI 2D (Bypass Angioplasty Revascularization Investigation 2 Diabetes)
por: Ghasemzadeh, Nima, et al.
Publicado: (2017)

Update on the Management of Diabetic Neuropathy
por: Ang, Lynn, et al.
Publicado: (2018)

A Genetic Locus on Chromosome 2q24 Predicting Peripheral Neuropathy Risk in Type 2 Diabetes: Results From the ACCORD and BARI 2D Studies
por: Tang, Yaling, et al.
Publicado: (2019)

Neuropathy and Related Findings in the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study
por: Martin, Catherine L., et al.
Publicado: (2014)

Increased Hazard of Myocardial Infarction With Insulin‐Provision Therapy in Actively Smoking Patients With Diabetes Mellitus and Stable Ischemic Heart Disease: The BARI 2D (Bypass Angioplasty Revascularization Investigation 2 Diabetes) Trial
por: Khan, Asrar A., et al.
Publicado: (2017)

Burden of Diabetic Peripheral Neuropathy in Pima Indians With Type 2 Diabetes
por: Jaiswal, Mamta, et al.
Publicado: (2016)

Response to Comment on Jaiswal et al. Prevalence of and Risk Factors for Diabetic Peripheral Neuropathy in Youth With Type 1 and Type 2 Diabetes: SEARCH for Diabetes in Youth Study. Diabetes Care 2017;40:1226–1232
por: Jaiswal, Mamta, et al.
Publicado: (2018)

Elevated Triglycerides Correlate With Progression of Diabetic Neuropathy
por: Wiggin, Timothy D., et al.
Publicado: (2009)

Identification of Factors Associated With Sural Nerve Regeneration and Degeneration in Diabetic Neuropathy
por: Hur, Junguk, et al.
Publicado: (2013)

Diabetic Neuropathy: A Position Statement by the American Diabetes Association
por: Pop-Busui, Rodica, et al.
Publicado: (2017)

Association of Glycemic Variability in Type 1 Diabetes With Progression of Microvascular Outcomes in the Diabetes Control and Complications Trial
por: Lachin, John M., et al.
Publicado: (2017)

Prevalence and Determinants of Glycemic Abnormalities in Cardiac Surgery Patients without a History of Diabetes: A Prospective Study
por: Gianchandani, Roma Y., et al.
Publicado: (2015)

Response to Comment on Mizokami-Stout et al. The Contemporary Prevalence of Diabetic Neuropathy in Type 1 Diabetes: Findings From the T1D Exchange. Diabetes Care 2020;43:806–812
por: Mizokami-Stout, Kara R., et al.
Publicado: (2020)

Impaired Amino Acid and TCA Metabolism and Cardiovascular Autonomic Neuropathy Progression in Type 1 Diabetes
por: Mathew, Anna V., et al.
Publicado: (2019)

Diabetes and obesity are the main metabolic drivers of peripheral neuropathy
por: Callaghan, Brian C., et al.
Publicado: (2018)

Associations Between Oral Health Status and Diabetic Neuropathy in a Large Romanian Cohort of Patients With Diabetes
por: Jivanescu, Anca, et al.
Publicado: (2018)

Urinary epidermal growth factor levels correlate with cardiovascular autonomic neuropathy indices in adults with type 1 diabetes
por: Lin, Yu Kuei, et al.
Publicado: (2023)

Hypoglycemia unawareness and autonomic dysfunction in diabetes: Lessons learned and roles of diabetes technologies
por: Lin, Yu Kuei, et al.
Publicado: (2020)

Response to Comment on Lachin et al. Association of Glycemic Variability in Type 1 Diabetes With Progression of Microvascular Outcomes in the Diabetes Control and Complications Trial. Diabetes Care 2017;40:777–783
por: Lachin, John M., et al.
Publicado: (2017)

Changes in salivary biomarkers associated with periodontitis and diabetic neuropathy in individuals with type 1 diabetes
por: Steigmann, Larissa, et al.
Publicado: (2022)

Death at Bari
Publicado: (1985)

Effect of Prior Intensive Insulin Treatment During the Diabetes Control and Complications Trial (DCCT) on Peripheral Neuropathy in Type 1 Diabetes During the Epidemiology of Diabetes Interventions and Complications (EDIC) Study
por: Albers, James W., et al.
Publicado: (2010)

Accessibility and Openness to Diabetes Management Support With Mobile Phones: Survey Study of People With Type 1 Diabetes Using Advanced Diabetes Technologies
por: Lin, Yu Kuei, et al.
Publicado: (2022)

Empirical Antibiotic Therapy in Diabetic Foot Ulcer Infection Increases Hospitalization
por: Schmidt, Brian M, et al.
Publicado: (2023)

Utility of using electrocardiogram measures of heart rate variability as a measure of cardiovascular autonomic neuropathy in type 1 diabetes patients
por: Pop‐Busui, Rodica, et al.
Publicado: (2021)

De Bary on Bacteria
Publicado: (1888)

Vibration Perception Threshold as a Measure of Distal Symmetrical Peripheral Neuropathy in Type 1 Diabetes: Results from the DCCT/EDIC study
por: Martin, Catherine L., et al.
Publicado: (2010)

CMR for evaluation of cardiac function in Type-1 diabetes
por: Ibrahim, El-Sayed H, et al.
Publicado: (2016)

Prevalence of and Risk Factors for Diabetic Peripheral Neuropathy in Youth With Type 1 and Type 2 Diabetes: SEARCH for Diabetes in Youth Study
por: Jaiswal, Mamta, et al.
Publicado: (2017)

Los Bari: cultura del pueblo motilón
por: Antonio de Alcácer, 1929-
Publicado: (1964)

Association of Diabetic Neuropathy with Duration of Type 2 Diabetes and Glycemic Control
por: Nisar, Muhammad Umer, et al.
Publicado: (2015)

Glycemic Variability and Diabetic Neuropathy in Young Adults With Type 1 Diabetes
por: Christensen, Marie Mathilde Bjerg, et al.
Publicado: (2020)

Peripheral Neuropathy in Adolescents and Young Adults With Type 1 and Type 2 Diabetes From the SEARCH for Diabetes in Youth Follow-up Cohort: A pilot study
por: Jaiswal, Mamta, et al.
Publicado: (2013)

COVID-19 and Diabetes: A Collision and Collusion of Two Diseases
por: Feldman, Eva L., et al.
Publicado: (2020)

Perspectives of glycemic variability in diabetic neuropathy: a comprehensive review
por: Zhang, Xiaochun, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_cvjalef2m31lke7jfgb6nrdiu9